South America Poultry Vaccines Market is expected to reach US$ 277.90 Mn by 2028

Live Attenuated Vaccines Segment to Dominate SAM Poultry Vaccines Market During 2021–2028 

According to The Insight Partners market research study on “SAM Poultry Vaccines Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Dosage, Disease, and Technology” is expected to reach US$ 277.90 million by 2028 from US$ 183.82 million in 2021. The market is estimated to grow at a CAGR of 6.1% from 2021 to 2028. The report provides trends prevailing in the SAM poultry vaccines market along with the drivers and restraints pertaining to the market growth. Escalating market consolidation and advent of market in untapped economies are the major factor driving the growth of the SAM poultry vaccines market. However, inactivation of the vaccine after vaccination and managemental, technical and practical problems in poultry vaccines hinders the growth of SAM poultry vaccines market.     

In case of COVID-19, SAM is highly affected specially Brazil. SAM have been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases reached 34 million. The COVID-19 pandemic presented numerous impacts on health systems, social life, and human behavior worldwide. It remains a challenge for local communities. In Brazil, a decrease in the poultry vaccines was observed despite efforts to keep the treatment routine as normal as possible in animals. Nevertheless, a higher decrease in the total number of sales in poultry meat was detected, indicating huge losses. Moreover, the sharp drop in domestic consumption, notably in foodservice, coupled with rising appreciation of feed costs, resulted to reduced production. Although after the relaxation of the lockdown the market saw a slight recovery in the live animal stock price, but frozen or chilled meat still faced a huge loss due to the rumors of being the carrier of the deadly COVID-19 virus. After being prompted by many restrictions imposed on brick-and-mortar stores and the interruption of the entire supply channel, most consumers in the country market dealt with the outbreak of the COVID-19 pandemic in terms of stocking consumption goods. Thus, the above factors show a negative impact on poultry industry leading to negative impact on the poultry vaccine too.

The SAM poultry vaccines market has been segmented into the dosage, disease, technology, and country. Based on dosage, market has been segmented into the duct vaccines, liquid vaccines, and freeze-dried vaccines. The liquid vaccines segment dominated the SAM poultry vaccines market in 2020 and is also expected to be fastest growing during forecast period. Based on disease, market has been segmented into infectious bronchitis, avian influenza, Marek’s disease, Newcastle disease, and others. The infectious bronchitis segment dominated the SAM poultry vaccines market in 2020 and avian influenza segment is expected to be fastest growing during forecast period. Based on technology, market has been segmented into toxoid vaccines, recombinant vaccines, inactivated vaccines, live attenuated vaccines, and others. The live attenuated vaccines segment dominated the SAM poultry vaccines market in 2020 and recombinant vaccines segment is expected to be fastest growing during forecast period.  

Boehringer Ingelheim International GmbH; CEVA; Merck & Co., Inc.; PHIBRO POULTRY VACCINES CORPORATION; Virbac; and Zoetis Inc. are among the leading companies in the SAM poultry vaccines market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Boehringer Ingelheim has launched VAXXITEK HVT+IBD+ND. The vaccines provide a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.

The Report Segments the SAM Poultry Vaccines Market as Follows:

SAM Poultry Vaccines Market – By Dosage

• Duct Vaccines
• Liquid Vaccines
• Freeze-Dried Vaccines

SAM Poultry Vaccines Market – By Disease

• Infectious Bronchitis
• Avian Influenza
• Marek’s Disease
• Newcastle Disease
• Others

SAM Poultry Vaccines Market – By Technology

• Toxoid Vaccines
• Recombinant Vaccines
• Inactivated Vaccines  
• Live Attenuated Vaccines       
• Others

SAM Poultry Vaccines Market – By Country

• Brazil
• Argentina
• Rest of SAM